ARCHIVES

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded

September 28, 1990

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

March 21, 2008

Doctors Are Doing More Cancer Screening, ACS Survey Finds

March 30, 1990

NCI RFP Available.

February 18, 2000

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002